|
| Press Releases |
|
 |
|
| Thursday, June 18, 2020 |
|
|
Novotech Partners with South Korea's Pusan National University Hospital |
| The leading Asia-Pacific biotech specialist CRO Novotech has partnered with South Korea's world-class 1,300-bed Pusan National University Hospital (PNUH) based in Busan, South Korea's second largest city. more info >> |
|
| Tuesday, May 26, 2020 |
|
|
Novotech and Endpoints to present APAC Clinical Trial webinar series |
| Leading Asia-Pacific biotech specialist CRO Novotech will collaborate with Endpoints, the independent biotech news platform, for a series of webinars on the advantages of conducting clinical trials in the Asia-Pacific. more info >> |
|
| Wednesday, April 29, 2020 |
|
|
Novotech Selected as CRO for Karyopharm's COVID-19 Clinical Study |
| The Asia-Pacific's largest specialist biotech CRO Novotech has been engaged for a Phase 2 COVID-19 study by biotech sponsor Karyopharm Therapeutics Inc. more info >> |
|
| Tuesday, April 28, 2020 |
|
|
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes |
| Asia-Pacific's largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients' clinical trials with expedited review processes for treatment and vaccine candidates. more info >> |
|
| Wednesday, April 8, 2020 |
|
|
Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity |
| Asia-Pacific's largest specialist biotech CRO Novotech said the top 10 biotech sites in Australia were open for clinical trial activity with many sites modifying their practices to ensure continuity of operations. more info >> |
|
| Friday, March 20, 2020 |
|
|
Novotech CRO Tapped for Two Informa Citeline Awards for Excellence in Asia-Pacific Clinical Trials |
| Asia-Pacific's largest specialist biotech CRO Novotech has been selected as a finalist for two of the prestigious Citeline Awards 2020 (formerly CARE Awards) by Informa Pharma Intelligence. more info >> |
|
| Friday, March 6, 2020 |
|
|
Novotech Wins CRO Contract for Komipharm Coronavirus Covid-19 Clinical Trial in South Korea |
| Asia-Pacific's largest specialist biotech CRO Novotech has been selected for the Komipharm International clinical trials of Panaphix as a potential treatment for coronavirus - Covid-19. more info >> |
|
| Tuesday, January 21, 2020 |
|
|
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO |
| Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for number of studies, experienced world-class sites and investigators, and patient enrolment. more info >> |
|
| Thursday, July 11, 2019 |
|
|
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research |
| Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in skin research clinical trials. more info >> |
|
| Friday, May 31, 2019 |
|
|
Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO |
| Novotech, the Asia-Pacific CRO, has again won the prestigious Asia-Pacific CRO of the year awarded by leading analyst firm Frost & Sullivan. This is the fifth year Novotech has been awarded the top CRO for the region which focusses on best practices in clinical research for biotechs. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Wintermar Offshore (WINS:JK) Reports 1H2025 Results
Jul 30, 2025 19:56 HKT/SGT
|
|
|
Hong Kong Shopping Festival Returns in August with Bigger and Better 2nd Edition
Jul 30, 2025 18:29 HKT/SGT
|
|
|
Production, Sales and Export Results for June, 2025
Jul 30, 2025 18:24 JST
|
|
|
Sales, Production, and Export Results for the First Half of 2025
Jul 30, 2025 18:06 JST
|
|
|
Introducing the Meshy 5 Preview: Smarter AI, Cleaner Models, Bigger Animation Potential 
Jul 30, 2025 17:00 JST
|
|
|
Ongoing Share Buybacks Demonstrate Confidence, Shoucheng Holdings Boosts Market Expectations with Concrete Action
Jul 30, 2025 11:00 HKT/SGT
|
|
|
Collaborative Development of Ultra-Compact and Lightweight Satellite Communication User Terminals for Mobility with Mitsubishi Chemical, NICT, and TECHLAB
Jul 30, 2025 11:00 JST
|
|
|
Naoris Protocol Announces Upcoming TGE for $NAORIS
Jul 29, 2025 23:59 HKT/SGT
|
|
|
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Jul 29, 2025 23:13 HKT/SGT
|
|
|
Mitsubishi Heavy Industries Concludes Agreement with Modius to Provide DCIM Solutions for Data Centers Worldwide
Jul 29, 2025 20:00 JST
|
|
|
Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence
Jul 29, 2025 16:00 HKT/SGT
|
|
|
Set at the Osaka-Kansai Expo venue! Detailed program announced for the "OSAKA JAPAN SDGs Forum"
Jul 29, 2025 14:30 JST
|
|
|
GTJAI Achieved 'Carbon Neutrality' at Operational Level for the Third Consecutive Year
Jul 29, 2025 13:15 HKT/SGT
|
|
|
Unitree Races Toward IPO as Robot Applications Accelerate: Shoucheng Holdings Unlocks Dual-Engine Gains
Jul 29, 2025 11:30 HKT/SGT
|
|
|
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Jul 29, 2025 9:01 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
